The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-410X.2003.04479.x/fullpdf
Reference12 articles.
1. Cancer statistics 2003;Jemal;CA Cancer J Clin,2003
2. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999
3. Maximum androgen blockade in advanced prostate cancer. An overview of 22 randomised trials with 3283 deaths in 5710 patients;Prostate Cancer Trialists’ Collaborative Group.;Lancet,1995
4. Treatment and survival of patients with cancer of the prostate;The Veterans Administration Co-operative Urological Research Group.;Surg Gynecol Obstet,1967
5. Byar DP Corle DK Hormone therapy for prostate cancer. Results of the Veterans Administration Cooperative Urological Research Group studies NCI Monogr 1988 :
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A combined in vitro-in silico method for assessing the androgenic activities of bisphenol A and its analogues;Toxicology in Vitro;2024-06
2. ARe we there yet? Understanding androgen receptor signaling in breast cancer;npj Breast Cancer;2020-09-25
3. Low-dose rate brachytherapy for men with localized prostate cancer;Cochrane Database of Systematic Reviews;2011-07-06
4. Effects of in Utero Exposure to DI(n-Butyl) Phthalate on Development of Male Reproductive Tracts in Sprague-Dawley Rats;Journal of Toxicology and Environmental Health, Part A;2010-11
5. Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long-term follow-up;BJU International;2009-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3